Register Cart 0

Generic placeholder image

Current Medicinal Chemistry - Central Nervous System Agents

Editor-in-Chief

ISSN (Print): 1568-0150
ISSN (Online): 1875-6158

Back Subscribe

Introduction: Strategies, Molecular Targets and Animal Models Useful for Developing Therapies for Alzheimers Disease

Author(s): H. Uri Saragovi

Volume 5, Issue 1, 2005

Page: [1 - 3] Pages: 3

DOI: 10.2174/1568015053202778

Price: $65

conference banner

Abstract

Next »

Rights & Permissions Print Cite

Article Metrics

14

Related Articles

Pharmacological Properties of Physical Exercise in The Elderly
Current Pharmaceutical Design

IL-8 and MCP-1 Impact on Tau Phosphorylation and Phosphatase Activity
Current Alzheimer Research

Relevant Modulation by Ferrous Ions of N-Methyl-D-Aspartate Receptors in Ischemic Brain Injuries
Current Neurovascular Research

Mathematical Modelling and Feature Extraction for Probing Crucial Changes Associated with Alzheimers Disease
Current Medical Imaging

Hippocampal BDNF Expression in a Tau Transgenic Mouse Model
Current Alzheimer Research

Cerium Oxide Nanoparticles Trigger Neuronal Survival in a Human Alzheimer Disease Model By Modulating BDNF Pathway
Current Nanoscience

The Effect of Acori Graminei Rhizoma and Extract Fractions on Spatial Memory and Hippocampal Neurogenesis in Amyloid Beta 1-42 Injected Mice
CNS & Neurological Disorders - Drug Targets

NAP (Davunetide) Provides Functional and Structural Neuroprotection
Current Pharmaceutical Design

The Application of Minerals in Managing Alcohol Hangover: A Preliminary Review
Current Drug Abuse Reviews

The Potential Use of Hormone-Based Therapeutics for the Treatment of Alzheimers Disease
Current Alzheimer Research

Regulation of Gene Expression by TDP-43 and FUS/TLS in Frontotemporal Lobar Degeneration
Current Alzheimer Research

Neuroinflammation, Oxidative Stress and the Pathogenesis of Alzheimers Disease
Current Pharmaceutical Design

Commentary [Research Highlights : Neurotrophic Factor Treatment of Neurological Disorders: The Benefits of a Pleiotropic Treatment Approach]
CNS & Neurological Disorders - Drug Targets

Nano-Neurotherapeutics (NNTs): An Emergent and Multifaceted Tool for CNS Disorders
Current Drug Metabolism

Alzheimers Disease and Intelligence
Current Alzheimer Research

Preface
Combinatorial Chemistry & High Throughput Screening

Kinematic and Pressure Features of Handwriting and Drawing: Preliminary Results Between Patients with Mild Cognitive Impairment, Alzheimer Disease and Healthy Controls
Current Alzheimer Research

Treatment of Insulin Resistance in the Neurodegeneration
Recent Patents on CNS Drug Discovery (Discontinued)

Obstructive Sleep Apnea Syndrome and Upper Airway Inflammation
Recent Patents on Inflammation & Allergy Drug Discovery

Basic and Clinical Research Against Advanced Glycation End Products (AGEs): New Compounds to Tackle Cardiovascular Disease and Diabetic Complications
Recent Advances in Cardiovascular Drug Discovery (Discontinued)

© 2024 Bentham Science Publishers | Privacy Policy